83 related articles for article (PubMed ID: 23768930)
1. Administration of ATRA to newly diagnosed patients with acute promyelocytic leukemia is delayed contributing to early hemorrhagic death.
Altman JK; Rademaker A; Cull E; Weitner BB; Ofran Y; Rosenblat TL; Haidau A; Park JH; Ram SL; Orsini JM; Sandhu S; Catchatourian R; Trifilio SM; Adel NG; Frankfurt O; Stein EM; Mallios G; Deblasio T; Jurcic JG; Nimer S; Peterson LC; Kwaan HC; Rowe JM; Douer D; Tallman MS
Leuk Res; 2013 Sep; 37(9):1004-9. PubMed ID: 23768930
[TBL] [Abstract][Full Text] [Related]
2. Disparities in early death and survival in children, adolescents, and young adults with acute promyelocytic leukemia in California.
Abrahão R; Ribeiro RC; Medeiros BC; Keogh RH; Keegan TH
Cancer; 2015 Nov; 121(22):3990-7. PubMed ID: 26264598
[TBL] [Abstract][Full Text] [Related]
3. [Effects of Cytokines on Early Death in Patients with Newly Diagnosed Acute Promyelocytic Leukemia].
Zhao SX; Ge YY; Li ZZ; He HP; Shen CM; Shi KQ; Yang TH; DU YY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Oct; 31(5):1315-1321. PubMed ID: 37846678
[TBL] [Abstract][Full Text] [Related]
4. Complications and early mortality in patients with acute promyelocytic leukemia treated in California.
Ho G; Li Q; Brunson A; Jonas BA; Wun T; Keegan THM
Am J Hematol; 2018 Nov; 93(11):E370-E372. PubMed ID: 30105792
[No Abstract] [Full Text] [Related]
5. Early death risk score in acute promyelocytic leukemia: A retrospective analysis from a monocentric cohort.
Costa A; Carmosino I; Scalzulli E; Minotti C; De Propris MS; Masucci C; Passucci M; Bisegna ML; Ielo C; Pepe S; Diverio D; Martelli M; Breccia M
Eur J Haematol; 2024 Apr; 112(4):654-657. PubMed ID: 38093665
[No Abstract] [Full Text] [Related]
6. How we prevent and treat differentiation syndrome in patients with acute promyelocytic leukemia.
Sanz MA; Montesinos P
Blood; 2014 May; 123(18):2777-82. PubMed ID: 24627526
[TBL] [Abstract][Full Text] [Related]
7. Incidence, clinical features, and outcome of all trans-retinoic acid syndrome in 413 cases of newly diagnosed acute promyelocytic leukemia. The European APL Group.
De Botton S; Dombret H; Sanz M; Miguel JS; Caillot D; Zittoun R; Gardembas M; Stamatoulas A; Condé E; Guerci A; Gardin C; Geiser K; Makhoul DC; Reman O; de la Serna J; Lefrere F; Chomienne C; Chastang C; Degos L; Fenaux P
Blood; 1998 Oct; 92(8):2712-8. PubMed ID: 9763554
[TBL] [Abstract][Full Text] [Related]
8. Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet.
Sanz MA; Fenaux P; Tallman MS; Estey EH; Löwenberg B; Naoe T; Lengfelder E; Döhner H; Burnett AK; Chen SJ; Mathews V; Iland H; Rego E; Kantarjian H; Adès L; Avvisati G; Montesinos P; Platzbecker U; Ravandi F; Russell NH; Lo-Coco F
Blood; 2019 Apr; 133(15):1630-1643. PubMed ID: 30803991
[TBL] [Abstract][Full Text] [Related]
9. Predictive factors of fatal bleeding in acute promyelocytic leukemia.
Mantha S; Tallman MS; Devlin SM; Soff GA
Thromb Res; 2018 Apr; 164 Suppl 1():S98-S102. PubMed ID: 29703492
[TBL] [Abstract][Full Text] [Related]
10. Determinants of fatal bleeding during induction therapy for acute promyelocytic leukemia in the ATRA era.
Mantha S; Goldman DA; Devlin SM; Lee JW; Zannino D; Collins M; Douer D; Iland HJ; Litzow MR; Stein EM; Appelbaum FR; Larson RA; Stone R; Powell BL; Geyer S; Laumann K; Rowe JM; Erba H; Coutre S; Othus M; Park JH; Wiernik PH; Tallman MS
Blood; 2017 Mar; 129(13):1763-1767. PubMed ID: 28082441
[TBL] [Abstract][Full Text] [Related]
11. The influence of hospital volume and physician volume on early mortality in acute promyelocytic leukemia patients.
Wu CY; Yeh CM; Tsai CK; Liu CJ
Ann Hematol; 2024 May; 103(5):1577-1586. PubMed ID: 38532122
[TBL] [Abstract][Full Text] [Related]
12. Risk stratification for early mortality in newly diagnosed acute promyelocytic leukemia: a multicenter, non-selected, retrospective cohort study.
Kim S; Jung J; Ahn SY; Kim M; Jeon SY; Lee CH; Kim DS; Lee SR; Sung HJ; Choi CW; Kim BS; Kim HJ; Kwak JY; Park Y; Ahn JS; Yhim HY
Front Oncol; 2024; 14():1307315. PubMed ID: 38352893
[TBL] [Abstract][Full Text] [Related]
13. Dysregulated hemostasis in acute promyelocytic leukemia.
Hisada Y
Int J Hematol; 2024 May; 119(5):526-531. PubMed ID: 38341391
[TBL] [Abstract][Full Text] [Related]
14. Cancer-associated thrombosis in hematologic malignancies.
Fukatsu M; Ikezoe T
Int J Hematol; 2024 May; 119(5):516-525. PubMed ID: 38270784
[TBL] [Abstract][Full Text] [Related]
15. Editorial: Acute promyelocytic leukemia - towards a chemotherapy-free approach to cure in all patients, Volume II.
Gill H; Russell N; Kwong YL
Front Oncol; 2023; 13():1238486. PubMed ID: 37441418
[No Abstract] [Full Text] [Related]
16. Influence of cytokines on early death and coagulopathy in newly diagnosed patients with acute promyelocytic leukemia.
Zhao S; Ge Y; Li Z; Yang T
Front Immunol; 2023; 14():1100151. PubMed ID: 37063881
[TBL] [Abstract][Full Text] [Related]
17. Acute promyelocytic leukaemia: population-based study of epidemiology and outcome with ATRA and oral-ATO from 1991 to 2021.
Gill H; Raghupathy R; Lee CYY; Yung Y; Chu HT; Ni MY; Xiao X; Flores FP; Yim R; Lee P; Chin L; Li VWK; Au L; Au WY; Ma ESK; Mohan D; Kumana CR; Kwong YL
BMC Cancer; 2023 Feb; 23(1):141. PubMed ID: 36765318
[TBL] [Abstract][Full Text] [Related]
18. The treatment of acute promyelocytic leukemia in 2023: Paradigm, advances, and future directions.
Iyer SG; Elias L; Stanchina M; Watts J
Front Oncol; 2022; 12():1062524. PubMed ID: 36741714
[TBL] [Abstract][Full Text] [Related]
19. Acute promyelocytic leukemia in a long-standing HIV-positive patient: Case report and literature review.
Mendes-de-Almeida DP; Fernandez TS; Lovatel VL; da Rocha MM; Gomes BE; Monte-Mór BCR; Vianna DT; Alcoforado MTG; Kronemberg JMPB; Cardoso JPSC; Oliveira VDG; Bokel J; Vizzoni AG; Nunes EP; Grinsztejn B
Leuk Res Rep; 2022; 18():100339. PubMed ID: 35958242
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
